---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-069091"
form_type: "8-K"
ticker: null
cik: "0001394319"
company_name: "Tracon Pharmaceuticals, Inc."
filed_at: "2023-12-08T23:59:59+00:00"
generated_at: "2026-06-07T15:29:47.706451+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# TRACON receives Nasdaq delisting notice for non-compliance with market value and bid price rules; intends to appeal

## Summary
- Nasdaq determined TRACON failed to regain compliance with Market Value Rule ($35M minimum) and Minimum Bid Price ($1.00) by Dec 5, 2023 deadline.
- Suspension and delisting of common stock scheduled for Dec 15, 2023 unless TRACON appeals by Dec 13, 2023.
- Company intends to appeal before the Dec 13 deadline; appeal will stay suspension pending Hearings Panel decision.
- Hearing typically scheduled 30-45 days after request; Panel decision within 30 days of hearing. Outcome uncertain.

## SEC filing metadata
- accession: 0000950170-23-069091
- form_type: 8-K
- cik: 0001394319
- company_name: Tracon Pharmaceuticals, Inc.
- filed_at: 2023-12-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1394319/000095017023069091/0000950170-23-069091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1394319/000095017023069091/tcon-20231206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-069091
- JSON: https://secwatch.observer/filing/0000950170-23-069091.json
- Plain text: https://secwatch.observer/filing/0000950170-23-069091.txt

## Key facts
- Listing & Compliance Notices
  Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: ecutive business days preceding the date of the Notices, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Company was provided 180 calendar days, or until December 5, 2023, to regain compliance with one of the Financial and Liquidity Standards and the Minimum Bid Price Requirement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017023069091/0000950170-23-069091-index.htm
- Listing & Compliance Notices
  Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2), 5550(b)
  source text: i) for 30 consecutive business days preceding the date of the Notices, the market value of the Company’s common stock was less than $35.0 million, which does not meet the requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “Market Value Rule”) and the Company did not meet any of the alternative continued listing requirements set forth in Nasdaq Listing Rule 5550(b) (the “Financial and Liquidity Standards”), and (ii) for 30 consecutive business days preceding the date of the Notices, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017023069091/0000950170-23-069091-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.